Invention Grant
- Patent Title: Oxygen enhancing membrane systems for implantable devices
-
Application No.: US14529034Application Date: 2014-10-30
-
Publication No.: US09597027B2Publication Date: 2017-03-21
- Inventor: James R. Petisce , Mark A. Tapsak , Peter C. Simpson , Victoria Carr-Brendel , James H. Brauker
- Applicant: DexCom, Inc.
- Applicant Address: US CA San Diego
- Assignee: DexCom, Inc.
- Current Assignee: DexCom, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Knobbe Martens Olson & Bear, LLP
- Main IPC: A61B5/1486
- IPC: A61B5/1486 ; A61B5/1468 ; A61B5/1473 ; A61B5/145

Abstract:
The present invention relates generally to systems and methods for increasing oxygen availability to implantable devices. The preferred embodiments provide a membrane system configured to provide protection of the device from the biological environment and/or a catalyst for enabling an enzymatic reaction, wherein the membrane system includes a polymer formed from a high oxygen soluble material. The high oxygen soluble polymer material is disposed adjacent to an oxygen-utilizing source on the implantable device so as to dynamically retain high oxygen availability to the oxygen-utilizing source during oxygen deficits. Membrane systems of the preferred embodiments are useful for implantable devices with oxygen-utilizing sources and/or that function in low oxygen environments, such as enzyme-based electrochemical sensors and cell transplantation devices.
Public/Granted literature
- US20150057514A1 OXYGEN ENHANCING MEMBRANE SYSTEMS FOR IMPLANTABLE DEVICES Public/Granted day:2015-02-26
Information query